These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 20876802)
1. RasGRP3 contributes to formation and maintenance of the prostate cancer phenotype. Yang D; Kedei N; Li L; Tao J; Velasquez JF; Michalowski AM; Tóth BI; Marincsák R; Varga A; Bíró T; Yuspa SH; Blumberg PM Cancer Res; 2010 Oct; 70(20):7905-17. PubMed ID: 20876802 [TBL] [Abstract][Full Text] [Related]
2. Function of RasGRP3 in the formation and progression of human breast cancer. Nagy Z; Kovács I; Török M; Tóth D; Vereb G; Buzás K; Juhász I; Blumberg PM; Bíró T; Czifra G Mol Cancer; 2014 Apr; 13():96. PubMed ID: 24779681 [TBL] [Abstract][Full Text] [Related]
3. RasGRP3, a Ras activator, contributes to signaling and the tumorigenic phenotype in human melanoma. Yang D; Tao J; Li L; Kedei N; Tóth ZE; Czap A; Velasquez JF; Mihova D; Michalowski AM; Yuspa SH; Blumberg PM Oncogene; 2011 Nov; 30(45):4590-4600. PubMed ID: 21602881 [TBL] [Abstract][Full Text] [Related]
4. Upregulation of RASGRP3 expression in prostate cancer correlates with aggressive capabilities and predicts biochemical recurrence after radical prostatectomy. Zeng X; Hu Z; Wang Z; Tao J; Lu T; Yang C; Lee B; Ye Z Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):119-25. PubMed ID: 24418912 [TBL] [Abstract][Full Text] [Related]
5. RasGRP3, a Ras guanyl releasing protein 3 that contributes to malignant proliferation and aggressiveness in human esophageal squamous cell carcinoma. Zhang Z; Ma M; Hu R; Xu B; Zong L; Wei H; Meng Y Clin Exp Pharmacol Physiol; 2018 Jul; 45(7):720-728. PubMed ID: 29461644 [TBL] [Abstract][Full Text] [Related]
6. RasGRP3 controls cell proliferation and migration in papillary thyroid cancer by regulating the Akt-MDM2 pathway. Qiu W; Xia X; Qiu Z; Guo M; Yang Z Gene; 2017 Oct; 633():35-41. PubMed ID: 28864115 [TBL] [Abstract][Full Text] [Related]
7. Integration of DAG signaling systems mediated by PKC-dependent phosphorylation of RasGRP3. Teixeira C; Stang SL; Zheng Y; Beswick NS; Stone JC Blood; 2003 Aug; 102(4):1414-20. PubMed ID: 12730099 [TBL] [Abstract][Full Text] [Related]
8. A vascular gene trap screen defines RasGRP3 as an angiogenesis-regulated gene required for the endothelial response to phorbol esters. Roberts DM; Anderson AL; Hidaka M; Swetenburg RL; Patterson C; Stanford WL; Bautch VL Mol Cell Biol; 2004 Dec; 24(24):10515-28. PubMed ID: 15572660 [TBL] [Abstract][Full Text] [Related]
9. Importance of the REM (Ras exchange) domain for membrane interactions by RasGRP3. Czikora A; Kedei N; Kalish H; Blumberg PM Biochim Biophys Acta Biomembr; 2017 Dec; 1859(12):2350-2360. PubMed ID: 28912101 [TBL] [Abstract][Full Text] [Related]
10. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines. Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686 [TBL] [Abstract][Full Text] [Related]
11. Vav3 oncogene is overexpressed and regulates cell growth and androgen receptor activity in human prostate cancer. Dong Z; Liu Y; Lu S; Wang A; Lee K; Wang LH; Revelo M; Lu S Mol Endocrinol; 2006 Oct; 20(10):2315-25. PubMed ID: 16762975 [TBL] [Abstract][Full Text] [Related]
12. The Vav3 oncogene enhances the malignant potential of prostate cancer cells under chronic hypoxia. Hirai K; Nomura T; Yamasaki M; Inoue T; Narimatsu T; Chisato Nakada PD; Yoshiyuki Tsukamoto PD; Matsuura K; Sato F; Moriyama M; Mimata H Urol Oncol; 2014 Feb; 32(2):101-9. PubMed ID: 23403204 [TBL] [Abstract][Full Text] [Related]
13. Phorbol esters modulate the Ras exchange factor RasGRP3. Lorenzo PS; Kung JW; Bottorff DA; Garfield SH; Stone JC; Blumberg PM Cancer Res; 2001 Feb; 61(3):943-9. PubMed ID: 11221888 [TBL] [Abstract][Full Text] [Related]
14. Liprin-alpha2 gene, protein tyrosine phosphatase LAR interacting protein related gene, is downregulated by androgens in the human prostate cancer cell line LNCaP. Fujinami K; Uemura H; Ishiguro H; Kubota Y Int J Mol Med; 2002 Aug; 10(2):173-6. PubMed ID: 12119554 [TBL] [Abstract][Full Text] [Related]
15. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts. Chiu FL; Lin JK Prostate; 2008 Jan; 68(1):61-71. PubMed ID: 18008333 [TBL] [Abstract][Full Text] [Related]
16. S100A16 promotes cell proliferation and metastasis via AKT and ERK cell signaling pathways in human prostate cancer. Zhu W; Xue Y; Liang C; Zhang R; Zhang Z; Li H; Su D; Liang X; Zhang Y; Huang Q; Liu M; Li L; Li D; Zhao AZ; Liu Y Tumour Biol; 2016 Sep; 37(9):12241-12250. PubMed ID: 27240591 [TBL] [Abstract][Full Text] [Related]
17. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells. Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946 [TBL] [Abstract][Full Text] [Related]
18. Establishment and characterization of androgen-independent human prostate cancer cell lines, LN-REC4 and LNCaP-SF, from LNCaP. Iwasa Y; Mizokami A; Miwa S; Koshida K; Namiki M Int J Urol; 2007 Mar; 14(3):233-9. PubMed ID: 17430262 [TBL] [Abstract][Full Text] [Related]
19. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells. Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142 [TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of RasGRP3 on threonine 133 provides a mechanistic link between PKC and Ras signaling systems in B cells. Zheng Y; Liu H; Coughlin J; Zheng J; Li L; Stone JC Blood; 2005 May; 105(9):3648-54. PubMed ID: 15657177 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]